vs
Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and Northfield Bancorp, Inc. (NFBK). Click either name above to swap in a different company.
Northfield Bancorp, Inc. is the larger business by last-quarter revenue ($41.3M vs $38.3M, roughly 1.1× ImmunityBio, Inc.). ImmunityBio, Inc. runs the higher net margin — -161.8% vs -1545.5%, a 1383.7% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 12.7%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $-71.3M).
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.
IBRX vs NFBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $41.3M |
| Net Profit | $-61.9M | $-27.4M |
| Gross Margin | 99.0% | — |
| Operating Margin | -169.0% | -1263.3% |
| Net Margin | -161.8% | -1545.5% |
| Revenue YoY | 407.0% | 12.7% |
| Net Profit YoY | -4.7% | -343.6% |
| EPS (diluted) | $-0.06 | $-0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $41.3M | ||
| Q3 25 | $32.1M | $39.2M | ||
| Q2 25 | $26.4M | $38.9M | ||
| Q1 25 | $16.5M | $34.8M | ||
| Q4 24 | $7.6M | $36.7M | ||
| Q3 24 | $6.1M | $31.8M | ||
| Q2 24 | — | $31.5M | ||
| Q1 24 | — | $31.3M |
| Q4 25 | $-61.9M | $-27.4M | ||
| Q3 25 | $-67.3M | $10.8M | ||
| Q2 25 | $-92.6M | $9.6M | ||
| Q1 25 | $-129.6M | $7.9M | ||
| Q4 24 | $-59.2M | $11.3M | ||
| Q3 24 | $-85.7M | $6.5M | ||
| Q2 24 | — | $6.0M | ||
| Q1 24 | — | $6.2M |
| Q4 25 | 99.0% | — | ||
| Q3 25 | 99.4% | — | ||
| Q2 25 | 99.5% | — | ||
| Q1 25 | 99.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -169.0% | -1263.3% | ||
| Q3 25 | -173.5% | 37.7% | ||
| Q2 25 | -269.8% | 35.6% | ||
| Q1 25 | -390.1% | 31.0% | ||
| Q4 24 | -919.0% | 38.0% | ||
| Q3 24 | -1314.3% | 27.9% | ||
| Q2 24 | — | 29.1% | ||
| Q1 24 | — | 27.2% |
| Q4 25 | -161.8% | -1545.5% | ||
| Q3 25 | -209.8% | 27.4% | ||
| Q2 25 | -350.3% | 24.6% | ||
| Q1 25 | -784.9% | 22.6% | ||
| Q4 24 | -783.4% | 30.7% | ||
| Q3 24 | -1404.0% | 20.5% | ||
| Q2 24 | — | 18.9% | ||
| Q1 24 | — | 19.9% |
| Q4 25 | $-0.06 | $-0.68 | ||
| Q3 25 | $-0.07 | $0.27 | ||
| Q2 25 | $-0.10 | $0.24 | ||
| Q1 25 | $-0.15 | $0.19 | ||
| Q4 24 | $-0.08 | $0.27 | ||
| Q3 24 | $-0.14 | $0.16 | ||
| Q2 24 | — | $0.14 | ||
| Q1 24 | — | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.8M | $164.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-500.5M | $690.1M |
| Total Assets | $501.9M | $5.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.8M | $164.0M | ||
| Q3 25 | $257.8M | $131.7M | ||
| Q2 25 | $153.7M | $97.6M | ||
| Q1 25 | $61.6M | $101.7M | ||
| Q4 24 | $149.8M | $167.7M | ||
| Q3 24 | $130.4M | $232.9M | ||
| Q2 24 | — | $153.5M | ||
| Q1 24 | — | $238.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $666.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-500.5M | $690.1M | ||
| Q3 25 | $-524.3M | $719.6M | ||
| Q2 25 | $-570.7M | $710.3M | ||
| Q1 25 | $-591.4M | $711.1M | ||
| Q4 24 | $-489.1M | $704.7M | ||
| Q3 24 | $-745.1M | $699.6M | ||
| Q2 24 | — | $693.0M | ||
| Q1 24 | — | $698.4M |
| Q4 25 | $501.9M | $5.8B | ||
| Q3 25 | $519.0M | $5.7B | ||
| Q2 25 | $402.1M | $5.7B | ||
| Q1 25 | $303.8M | $5.7B | ||
| Q4 24 | $382.9M | $5.7B | ||
| Q3 24 | $364.6M | $5.7B | ||
| Q2 24 | — | $5.7B | ||
| Q1 24 | — | $5.9B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.95× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-70.4M | $53.7M |
| Free Cash FlowOCF − Capex | $-71.3M | $52.5M |
| FCF MarginFCF / Revenue | -186.2% | 127.1% |
| Capex IntensityCapex / Revenue | 2.4% | 2.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-308.8M | $89.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-70.4M | $53.7M | ||
| Q3 25 | $-68.9M | $13.9M | ||
| Q2 25 | $-79.7M | $14.1M | ||
| Q1 25 | $-85.9M | $9.4M | ||
| Q4 24 | $-85.1M | $31.1M | ||
| Q3 24 | $-98.8M | $14.0M | ||
| Q2 24 | — | $6.9M | ||
| Q1 24 | — | $4.2M |
| Q4 25 | $-71.3M | $52.5M | ||
| Q3 25 | $-69.6M | $13.6M | ||
| Q2 25 | $-80.8M | $13.9M | ||
| Q1 25 | $-87.0M | $9.2M | ||
| Q4 24 | $-87.3M | $30.0M | ||
| Q3 24 | $-101.6M | $13.7M | ||
| Q2 24 | — | $6.7M | ||
| Q1 24 | — | $3.8M |
| Q4 25 | -186.2% | 127.1% | ||
| Q3 25 | -217.2% | 34.6% | ||
| Q2 25 | -305.9% | 35.7% | ||
| Q1 25 | -526.9% | 26.3% | ||
| Q4 24 | -1155.4% | 81.6% | ||
| Q3 24 | -1663.2% | 43.2% | ||
| Q2 24 | — | 21.1% | ||
| Q1 24 | — | 12.1% |
| Q4 25 | 2.4% | 2.8% | ||
| Q3 25 | 2.3% | 0.8% | ||
| Q2 25 | 4.1% | 0.6% | ||
| Q1 25 | 6.8% | 0.7% | ||
| Q4 24 | 28.0% | 3.1% | ||
| Q3 24 | 45.7% | 0.7% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.29× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 2.76× | ||
| Q3 24 | — | 2.14× | ||
| Q2 24 | — | 1.16× | ||
| Q1 24 | — | 0.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
